🔎 Trials Near Me

Dachaigh › Scleroderma

Sgrùdaidhean clionaigeach Scleroderma a’ fastadh anns na SA

Tha 33 sgrùdaidhean airson Scleroderma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.

Bailtean leis na sgrùdaidhean as motha

Le stàit

Sgrùdaidhean air an ùrachadh o chionn ghoirid

Teacsa sgrùdaidh oifigeil (Beurla)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06655155

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05878717

FT839 in Autoimmune Diseases

A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07800871

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A’ fastadhÌre 2/3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06328777

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

A’ fastadhÌre 2
Aoisean 8 gu 60 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT03630211

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07295847

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT07090226

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07115745

A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06827977

Systemic Sclerosis DIet for GastrointESTinal Symptoms

A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT07402226

US Zamto-cel Autoimmune Diseases

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Ògmh 2026 · NCT06708845

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

A’ fastadhÌre 1
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06308978

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Suas gu aois 90 · Gach gnè · Air ùrachadh 12 Cèit 2026 · NCT01808937

Intralesional Injection of STS in Treatment of Calcinosis

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06672822

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06434363

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Màrt 2026 · NCT07047690

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT03844061

Open Label Treprostinil Raynaud's Study

A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT07112183

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.